1.
Stein Gold L, Lebwohl M, Bhatia N, DiRuggiero D, Jacobson A, Pillai R. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion. J of Skin [Internet]. 2020Oct.27 [cited 2024Jul.12];4(6):s79. Available from: https://jofskin.org/index.php/skin/article/view/1112